IDEAYA Biosciences, Inc. IDYA Return on equity

Return on equity at other companies

Bristol-Myers SquibbBMY

46.7%+17.8pp

AmgenAMGN

91.5%-7.7pp

WHW

Whitehawk TherapeuticsWHWK

-68.5%-86.2pp

Aura Biosciences, Inc.AURA

-95.6%+222pp

Tango TherapeuticsTNGX

-38.4%-10.5pp

Arcus BiosciencesRCUS

-90.8%+373pp

FAQ

What is IDEAYA Biosciences, Inc.'s return on equity?

IDEAYA Biosciences, Inc. (IDYA) reported return on equity of -14.3% in Q1 2026.

How has IDEAYA Biosciences, Inc.'s return on equity changed year-over-year?

IDEAYA Biosciences, Inc.'s return on equity increased by 54.4% year-over-year, from -31.3% to -14.3%.

What is the long-term trend for IDEAYA Biosciences, Inc.'s return on equity?

Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s return on equity has grown at a -13.9% compound annual growth rate (CAGR), from -23.1% to -10.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.